Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 3
2009 2
2010 1
2011 1
2012 1
2014 1
2016 2
2018 1
2019 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Chromosomal aberrations in iris melanomas.
Mensink HW, Vaarwater J, de Keizer RJ, de Wolff-Rouendaal D, Mooy CM, de Klein A, Paridaens D. Mensink HW, et al. Br J Ophthalmol. 2011 Mar;95(3):424-8. doi: 10.1136/bjo.2010.181289. Epub 2010 Sep 29. Br J Ophthalmol. 2011. PMID: 20881029
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
Bol KF, van den Bosch T, Schreibelt G, Mensink HW, Keunen JE, Kiliç E, Japing WJ, Geul KW, Westdorp H, Boudewijns S, Croockewit SA, van Rossum MM, de Goede AL, Naus NC, van der Graaf WT, Gerritsen WR, de Klein A, Punt CJ, Figdor CG, Cohen VM, Paridaens D, de Vries IJ. Bol KF, et al. Among authors: mensink hw. Ophthalmology. 2016 Oct;123(10):2265-7. doi: 10.1016/j.ophtha.2016.06.027. Epub 2016 Jul 29. Ophthalmology. 2016. PMID: 27476772 Clinical Trial. No abstract available.
Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
Drabarek W, Yavuzyigitoglu S, Obulkasim A, van Riet J, Smit KN, van Poppelen NM, Vaarwater J, Brands T, Eussen B, Verdijk RM, Naus NC, Mensink HW, Paridaens D, Boersma E, van de Werken HJG, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study Group. Drabarek W, et al. Among authors: mensink hw. Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3595-3605. doi: 10.1167/iovs.18-24818. Invest Ophthalmol Vis Sci. 2019. PMID: 31425584
Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.
Smit KN, Chang J, Derks K, Vaarwater J, Brands T, Verdijk RM, Wiemer EAC, Mensink HW, Pothof J, de Klein A, Kilic E. Smit KN, et al. Among authors: mensink hw. Cancers (Basel). 2019 Jun 12;11(6):815. doi: 10.3390/cancers11060815. Cancers (Basel). 2019. PMID: 31212861 Free PMC article.
Chromosome 3 intratumor heterogeneity in uveal melanoma.
Mensink HW, Vaarwater J, Kiliç E, Naus NC, Mooy N, Luyten G, Brüggenwirth HT, Paridaens D, de Klein A. Mensink HW, et al. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):500-4. doi: 10.1167/iovs.08-2279. Epub 2008 Sep 29. Invest Ophthalmol Vis Sci. 2009. PMID: 18824727
Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS). Yavuzyigitoglu S, et al. Among authors: mensink hw. Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2232-9. doi: 10.1167/iovs.15-18608. Invest Ophthalmol Vis Sci. 2016. PMID: 27116551
16 results